Jason Bouvier
Stock Analyst at Scotiabank
(1.48)
# 3,375
Out of 4,910 analysts
10
Total ratings
28.57%
Success rate
2.15%
Average return
Main Sectors:
Stocks Rated by Jason Bouvier
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
OVV Ovintiv | Maintains: Sector Outperform | $48 → $51 | $39.99 | +27.53% | 4 | Jul 11, 2025 | |
IMO Imperial Oil | Downgrades: Sector Perform | $110 | $84.09 | +30.81% | 2 | Sep 25, 2024 | |
SU Suncor Energy | Maintains: Sector Perform | $61 → $60 | $39.70 | +51.13% | 1 | Jul 12, 2024 | |
CVE Cenovus Energy | Maintains: Sector Outperform | $35 → $34 | $14.38 | +136.44% | 1 | Jul 12, 2024 | |
CNQ Canadian Natural Resources | Maintains: Sector Perform | $114 → $57 | $31.64 | +80.15% | 1 | Jun 11, 2024 | |
IKNA Ikena Oncology | Initiates: Buy | n/a | $1.37 | - | 1 | Apr 20, 2021 |
Ovintiv
Jul 11, 2025
Maintains: Sector Outperform
Price Target: $48 → $51
Current: $39.99
Upside: +27.53%
Imperial Oil
Sep 25, 2024
Downgrades: Sector Perform
Price Target: $110
Current: $84.09
Upside: +30.81%
Suncor Energy
Jul 12, 2024
Maintains: Sector Perform
Price Target: $61 → $60
Current: $39.70
Upside: +51.13%
Cenovus Energy
Jul 12, 2024
Maintains: Sector Outperform
Price Target: $35 → $34
Current: $14.38
Upside: +136.44%
Canadian Natural Resources
Jun 11, 2024
Maintains: Sector Perform
Price Target: $114 → $57
Current: $31.64
Upside: +80.15%
Ikena Oncology
Apr 20, 2021
Initiates: Buy
Price Target: n/a
Current: $1.37
Upside: -